Drug Type Antibody drug conjugate (ADC) |
Synonyms anti-ICAM1-SMCC-DM1 (Boston Children's Hospital) |
Target |
Action modulators, inhibitors |
Mechanism ICAM-1 modulators(Intercellular adhesion molecule-1 modulators), Tubulin inhibitors |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC35H48ClN3O10S |
InChIKeyANZJBCHSOXCCRQ-FKUXLPTCSA-N |
CAS Registry139504-50-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Cancer | Preclinical | United States | - |